Cargando…
Case Report: Malignant melanoma in a patient with Crohn’s disease treated with ustekinumab
The cornerstone of inflammatory bowel disease (IBD) treatment is immunomodulators. IBD patients are at increased risk of intestinal and extraintestinal malignancy. Ustekinumab is a fully humanized monoclonal anti-IL12/23 antibody with a good safety profile. Malignancies of breast, colon, head and ne...
Autores principales: | Axiaris, Georgios, Ioannou, Alexandros, Papoutsaki, Marina, Marinos, Leonidas, Liontos, Michael, Michopoulos, Spyridon, Zampeli, Evanthia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589619/ https://www.ncbi.nlm.nih.gov/pubmed/37867623 http://dx.doi.org/10.12688/f1000research.110356.2 |
Ejemplares similares
-
Management of hepatitis B virus infection in patients with inflammatory bowel disease under immunosuppressive treatment
por: Axiaris, Georgios, et al.
Publicado: (2021) -
Retroflexion, a costless endoscopic maneuver, increases adenoma detection rate in the ascending colon
por: Michopoulos, Spyridon, et al.
Publicado: (2021) -
Acute Pancreatitis Following Endoscopic Ampullary Biopsies without Attempted Cannulation of the Ampulla of Vater
por: Michopoulos, Spyridon, et al.
Publicado: (2016) -
Emerging treatments in the management of psoriasis: biological targeting with ustekinumab
por: Papoutsaki, Marina, et al.
Publicado: (2009) -
Clinical utility of ustekinumab in Crohn’s disease
por: Kotze, Paulo Gustavo, et al.
Publicado: (2018)